For Women
FDA Office of Women's Health has resources to help women make healthy choices for themselves and their loved ones. Check out the women's health resources and healthy living tips on this site.
Featured
![FDA Office of Women's Health Public Workshop Menopause: Potential Impact on Clinical Pharmacology and Opportunities for Future Research](https://public4.pagefreezer.com:443/content/FDA/21-09-2023T12:06/https://www.fda.gov/files/styles/medium_3/public/FDA_OWH_Menopause_EventMaterials_WebGraphic_1600x900_v2.jpg?itok=RCQMf6uu)
Menopause: Potential Impact on Clinical Pharmacology
Register today for OWH's free virtual public workshop on October 11 to discuss the current understanding of the impact of menopause on drug pharmacology and highlight the areas with the greatest need for further research and exploration.
![Cholesterol Education Month](https://public4.pagefreezer.com:443/content/FDA/21-09-2023T12:06/https://www.fda.gov/files/styles/medium_3/public/NationalCholesterolEducation_TW_noLogo.jpg?itok=4y6jR31t)
September is National Cholesterol Education Month
A time to raise awareness of the importance of knowing your cholesterol numbers and taking steps to prevent or reduce high cholesterol. Learn more about the different kinds of medicines that can help lower your cholesterol.
![PCOS Graphic](https://public4.pagefreezer.com:443/content/FDA/21-09-2023T12:06/https://www.fda.gov/files/styles/medium_3/public/iStock-1305106395.jpg?itok=_e8DboXe)
Polycystic Ovary Syndrome Awareness Month
Did you know Polycystic Ovary Syndrome (PCOS) is one of the most common causes of female infertility? In case you missed it, read our blog on PCOS to learn more about diagnosing and managing the condition and important research findings.
![PCOS](https://public4.pagefreezer.com:443/content/FDA/21-09-2023T12:06/https://www.fda.gov/files/styles/medium_3/public/PCOS-1359479215.jpg?itok=S4ArsG99)
PCOS Revisited: Diagnosis, Management, and Future Needs Webinar
OWH webinar "PCOS Revisited: Diagnosis, Management, and Future Needs" reviews the pathophysiology, diagnosis, comorbidities, and findings from recent research on Polycystic Ovary Syndrome (PCOS).
![Female customer at a pharmacy looking at different over the counter medicines.](https://public4.pagefreezer.com:443/content/FDA/21-09-2023T12:06/https://www.fda.gov/files/styles/medium_3/public/OTC%20Contraceptive_tw_7_6_23_1600x900_no%20logo_FINAL-01_0.png?itok=vVWBHr3V)
FDA Approves First Nonprescription Daily Oral Contraceptive
FDA approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy—the first daily oral contraceptive approved for use in the U.S. without a prescription.
![Women's Health Research](https://public4.pagefreezer.com:443/content/FDA/21-09-2023T12:06/https://www.fda.gov/files/styles/medium_3/public/Research_0.jpg?itok=o2suDc4y)
Women’s Health Research
We promote and conduct research initiatives that advance understanding of sex differences and health conditions unique to women.
Paragraph Header
Contact Us
Office of Women's Health
10903 New Hampshire Ave WO32-2333
Silver Spring, MD 20993